DOCSLIB.ORG

Download Thesis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download Thesis This electronic thesis or dissertation has been downloaded from the King’s Research Portal at https://kclpure.kcl.ac.uk/portal/ Radionuclide Dosimetry at Microscopic and Macroscopic Level in a Thyroid Model Chuamsaamarkkee, Krisanat Awarding institution: King's College London The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without proper acknowledgement. END USER LICENCE AGREEMENT Unless another licence is stated on the immediately following page this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ You are free to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work). Non Commercial: You may not use this work for commercial purposes. No Derivative Works - You may not alter, transform, or build upon this work. Any of these conditions can be waived if you receive permission from the author. Your fair dealings and other rights are in no way affected by the above. Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 23. Sep. 2021 Radionuclide Dosimetry at Microscopic and Macroscopic Level in a Thyroid Model A thesis submitted to King’s College London for the degree of Doctor of Philosophy in Imaging Sciences and Radiation Biology Krisanat Chuamsaamarkkee Division of Imaging Sciences and Biomedical Engineering King’s College London 2016 1 Abstract This study proposes to evaluate dosimetrically the feasibility of using rhenium isotopes (186Re and 188Re) in the form of perrhenate (which is also a substrate of the sodium iodide symporter, NIS) for the treatment of benign nodular thyroid disease and non-thyroidal NIS expressing tumours. While radioiodine (131I-NaI) has practical limitations, there is a window in which rhenium isotopes might offer greater therapeutic advantages. For instance, 186Re and 188Re-perrhenate have shorter half-life, higher energy beta particles, longer range and less abundant gamma photons thus reducing effective dose to the whole body and members of the public and family. Generally, dosimetry in nuclear medicine is considered only at macroscopic level with radionuclide uptake assumed to have a uniform distribution throughout the organ. However, this assumption is not always correct as radionuclides may or may not get incorporated into intracellular structures which, depending on the particular energy transfer mechanisms, may be influential. Therefore, an aim of this thesis was to study the effect of tracer localisation on microscopic and macroscopic dosimetry by using the thyroid as a model. First, a basic performance evaluation of preclinical imaging systems was carried out. The image-based quantification accuracy of SPECT radionuclides (99mTc, 123I and 188Re) and PET (18F) with regard to effect of object size, acquisition time and reconstruction parameters (number of iterations) were examined with a mouse-size micro-hollow sphere phantom. Quantification accuracy in small objects was attempted to be improved using phantom-derived correction factors (Chapter 2). Then, a series of in vivo experiments was carried out aimed at spatio-temporal quantification with the available SPECT NIS-radiotracers (99mTc-pertechnetate, 123I-NaI, 131I-NaI and 188Re-perrhenate) and a forthcoming clinical PET radiotracer (18F-tetrafluoroborate). These data demonstrated distinct differences of uptake patterns between metabolised (123I- and 131I-NaI) and non-metabolised tracers (18F-tetrafluoroborate, 99mTc-pertechnetate and 188Re-perrhenate), and also subtle differences between the non-metabolised tracers. Human-equivalent effective dose calculations for diagnostic use of these radiotracers were reported in this study. Dose estimations were conducted on the same strain sex- and age-matched animals to allow approximate comparison. Dosimetric estimations relevant to treatment of benign nodular thyroid disease indicated that rhenium isotopes were equally effective when excluding the highly variable uptake in the stomach and urinary bladder. The effective dose per unit of administered activity from 186Re and 188Re was lower than conventional radioiodine. Also red marrow absorbed dose 2 was about 1.5 and 3 times (for 186Re and 188Re respectively) lower than that produced by radioiodine. In xenograft bearing non-thyroidal NIS adenocarcinoma tumour (human NIS- engineered model), our data indicated that both rhenium isotopes delivered higher absorbed dose to the tumour (6.33 and 8.68 times higher for 186Re and 188Re) compared to 131I-NaI. Additionally, the therapy indexes (tumour to effective dose and tumour to thyroid ratio) for both rhenium isotopes were greater than 131I-NaI. An investigation of the radionuclide distribution at the microscopic level in thyroid tissue with electron microscopy and micro-autoradiography techniques illustrated that non-metabolised tracers were only located in thyrocytes whereas iodide was detected in the colloid. This information (thyroid geometrical model and tracer distribution) were used as an input for small-scale pilot dosimetry using the MCNPx (Monte Carlo N-particle extended) platform. The simulation results indicated that the mode of absorbed dose when 188Re distributed in thyrocytes was higher and more uniform when compared with 131I being located in the colloid. In conclusion, dose delivered to the thyroid is dependent on cellular distribution of radiotracers. The work presented in this thesis has been an important step for initial dosimetric estimates of the therapeutic potential of these radiotracers to inform future translation with pilot studies in humans. 3 Statement of Authorship I, the undersigned, hereby confirm that: o This submission is my own work and that to the best of my knowledge. o This work was done wholly or mainly while in candidature for a research degree at this university. o I have fully acknowledged and referenced the ideas and work of others, whether published or unpublished, in my thesis. o I have prepared my thesis specifically for the degree of Doctor of Philosophy, while under supervision at this university. o My thesis does not contain work extracted from a thesis, dissertation or research paper previously presented for another degree or diploma at this or any other university. (Mr. Krisanat Chuamsaamarkkee) Date 4 Table of Contents ABSTRACT .................................................................................................................................... 2 STATEMENT OF AUTHORSHIP ................................................................................................... 4 TABLE OF CONTENTS ................................................................................................................. 5 TABLE OF FIGURES ..................................................................................................................... 9 TABLE OF TABLES ..................................................................................................................... 17 ACKNOWLEDGEMENTS ............................................................................................................ 20 ABBREVIATIONS ........................................................................................................................ 22 CHAPTER 1 INTRODUCTION .................................................................................................... 25 1.1 INTRODUCTION ......................................................................................................................................... 25 1.2 THYROID .................................................................................................................................................. 28 1.2.1 Thyroid Anatomy ...................................................................................................................... 28 1.2.2 Thyroid Histology ...................................................................................................................... 29 1.2.3 Thyroid Hormones Synthesis and Physiology ........................................................................... 30 1.2.4 Iodine Kinetics and Sodium Iodide Symporter (NIS) ................................................................. 32 1.2.5 Radionuclide Imaging of Thyroid Gland .................................................................................... 33 1.2.6 Radionuclide Therapeutic of Thyroid Gland ............................................................................. 35 1.3 MICROSCOPIC AND MACROSCOPIC DOSIMETRY IN NUCLEAR MEDICINE ................................................................ 36 1.3.1 Macroscopic Dosimetry in Nuclear Medicine ........................................................................... 36 1.3.2 Microscopic Dosimetry in Nuclear Medicine ............................................................................ 36 1.4 THESIS OVERVIEW ..................................................................................................................................... 38 CHAPTER 2 QUANTITATIVE IMAGING WITH THE NANOSCAN SPECT/CT .......................... 39 2.1 INTRODUCTION ........................................................................................................................................
Load more

Recommended publications
  • Chemical Names and CAS Numbers Final
    Chemical Abstract Chemical Formula Chemical Name Service (CAS) Number C3H8O 1‐propanol C4H7BrO2 2‐bromobutyric acid 80‐58‐0 GeH3COOH 2‐germaacetic acid C4H10 2‐methylpropane 75‐28‐5 C3H8O 2‐propanol 67‐63‐0 C6H10O3 4‐acetylbutyric acid 448671 C4H7BrO2 4‐bromobutyric acid 2623‐87‐2 CH3CHO acetaldehyde CH3CONH2 acetamide C8H9NO2 acetaminophen 103‐90‐2 − C2H3O2 acetate ion − CH3COO acetate ion C2H4O2 acetic acid 64‐19‐7 CH3COOH acetic acid (CH3)2CO acetone CH3COCl acetyl chloride C2H2 acetylene 74‐86‐2 HCCH acetylene C9H8O4 acetylsalicylic acid 50‐78‐2 H2C(CH)CN acrylonitrile C3H7NO2 Ala C3H7NO2 alanine 56‐41‐7 NaAlSi3O3 albite AlSb aluminium antimonide 25152‐52‐7 AlAs aluminium arsenide 22831‐42‐1 AlBO2 aluminium borate 61279‐70‐7 AlBO aluminium boron oxide 12041‐48‐4 AlBr3 aluminium bromide 7727‐15‐3 AlBr3•6H2O aluminium bromide hexahydrate 2149397 AlCl4Cs aluminium caesium tetrachloride 17992‐03‐9 AlCl3 aluminium chloride (anhydrous) 7446‐70‐0 AlCl3•6H2O aluminium chloride hexahydrate 7784‐13‐6 AlClO aluminium chloride oxide 13596‐11‐7 AlB2 aluminium diboride 12041‐50‐8 AlF2 aluminium difluoride 13569‐23‐8 AlF2O aluminium difluoride oxide 38344‐66‐0 AlB12 aluminium dodecaboride 12041‐54‐2 Al2F6 aluminium fluoride 17949‐86‐9 AlF3 aluminium fluoride 7784‐18‐1 Al(CHO2)3 aluminium formate 7360‐53‐4 1 of 75 Chemical Abstract Chemical Formula Chemical Name Service (CAS) Number Al(OH)3 aluminium hydroxide 21645‐51‐2 Al2I6 aluminium iodide 18898‐35‐6 AlI3 aluminium iodide 7784‐23‐8 AlBr aluminium monobromide 22359‐97‐3 AlCl aluminium monochloride
    [Show full text]
  • Download Safety Data Sheet
    CMI Product #1022 Issued 06/15/15 Safety Data Sheet 29 CFR 1910.1200 Section 1: Company and Product Identification Product Name: Sodium perrhenate Product Code: 1022 Company: Colonial Metals, Inc. Building 20 505 Blue Ball Road Elkton, MD 21921 United States Company Contact: EHS Director www.colonialmetals.com Telephone Number: 410-398-7200 FAX Number: 410-398-2918 E-Mail : [email protected] Web Site: www.colonialmetals.com Emergency Supplier Emergency Contacts & Phone Number Response: Chemtrec: 800-424-9300 World Wide - Call COLLECT to U.S: 703-527-3887 Section 2: Hazards Identification GHS07 GHS03 BLANK BLANK Hazard Pictograms: Signal Word: Warning Hazard Category: Serious eye damage/eye irritation Cat 2 Skin corrosion/irritation Cat 2 Specific target organ tox, single exp. Cat 3 (resp irrit) Oxidizer Cat 2 Hazard Statements: H319: Causes serious eye irritation H315: Causes skin irritation H335: May cause respiratory irritation H272: May intensify fire; oxidizer Precautionary P202: Do not handle until all safety precautions have been read and understood Statements: P210: Keep away from heat/sparks/open flames/hot surfaces – No smoking P264: Wash thoroughly after handling P280: Wear protective gloves/protective clothing/eye protection/face protection P305+351+338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing P402+404: Store in a dry place. Store in a closed container P501: Dispose of contents/container in accordance with local/national/international rules. Not applicable, none known. The toxicological properties of this material have not been Hazards not fully investigated. This product is considered non-hazardous when evaluated by criteria otherwise classified: established in the OSHA Hazard Communication Standard (29 CFR 1910.1200).
    [Show full text]
  • Rhenium and Technetium (Vi) and Meso-(Vii) Species
    J. inorg,nucl. Chem.. 1969, Vol. 31. pp. 33 to 41. PergamonPress. Printedin Grear Britain RHENIUM AND TECHNETIUM (VI) AND MESO-(VII) SPECIES S. K. MAJUMDAR, R. A. PACER and C. L. RULFS Department of Chemistry, University of Michigan Ann Arbor, Mich. 48104 (Received 17 May 1968) Abstract-Spectrophotometric study shows that less than 35 per cent of normal perrhenate converts to a meso form in 15 M base, and Kr - 0.1. The species absorbs at 260 m/z (~= 6,400) and near 3 l0 m/z (, ~ 1,400), overlapping the normal perrhenate features. Reflectance spectra on an isolabte barium salt, Baa(ReOs)~, confirm this resolution of the curve components. The variation of the barium salt solubility with concentration of aqueous hydroxide ion is consistent with the equilibrium deduced from spectrophotometry. Hydration is found for this salt and does not require the postulation of a dimeric form (to maintain 6-coordination); nor does this postulate seem to fit the equilibrium data or the i.r. absorption. No detectable amount of a comparable mesopertechnetate species is found in aqueous media of any alkalinity. However, pertechnetate fused in sodium hydroxide does give new absorption at 345,420 and (- 570) mp. (of relative ~ ca. 8/4/1), which is probably due to meso (or, ortho) species. Attempts to isolate a (VI) salt, BaTcO4, from hydrazine-reduced (Vll) in alkaline aqueous media, result in mixtures. Disproportionation of the intermediate state forms TcO2, and incidental BaCOa gives "products" of high Tc/Ba ratio. The red intermediate is more likely to be a Tc(V) species.
    [Show full text]
  • Molecular Rhenium and Molybdenum-Based (Pre)Catalysts for the Deoxydehydration of Vicinal Diols and Biomass-Derived Polyols
    Molecular Rhenium and Molybdenum-based (pre)catalysts for the deoxydehydration of vicinal diols and biomass-derived polyols Moleculaire Rhenium- en Molybdeen-(pre)katalysatoren voor de deoxydehydratatie van vicinale diolen en, van biomassa-afgeleide, polyolen (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof.dr. H.R.B.M. Kummeling ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op woensdag 8 juli 2020 des middags te 2.30 uur door Jing Li geboren op 12 oktober 1989 te Jiangsu, China Promotor: Prof. dr. R.J.M. Klein Gebbink The work described in this Ph.D. thesis was financially supported by the China Scholarship Council (CSC). Molecular Rhenium and Molybdenum-based (pre)catalysts for the deoxydehydration of vicinal diols and biomass-derived polyols Dedicated to my family 献给我的家人 Li, Jing Molecular Rhenium and Molybdenum-based (pre)catalysts for the deoxydehydration of vicinal diols and biomass-derived polyols ISBN: 978-94-6375-957-1 The work described in this PhD thesis was carried out at: Organic Chemistry and Catalysis, Debye Institute for Nanomaterials Science, Faculty of Science, Utrecht University, Utrecht, The Netherlands Print: Ridderprint | www.ridderprint.nl. Cover designer: 大吉设 平面设计 Table of Contents Chapter 1 Homogeneous Transition Metal-Catalyzed Deoxydehydration 1 of Biomass Derived Diols and Polyols Chapter 2 A Cptt-based Trioxo-Rhenium Catalyst for the Deoxydehydration 53 of Diols
    [Show full text]
  • Method of Preparation for High-Purity Nanocrystalline Anhydrous Cesium Perrhenate
    metals Article Method of Preparation for High-Purity Nanocrystalline Anhydrous Cesium Perrhenate Katarzyna Leszczy ´nska-Sejda*, Grzegorz Benke, Mateusz Ciszewski, Joanna Malarz and Michał Drzazga Institute of Non Ferrous Metals, Hydrometallurgy Department, ul. Sowi´nskiego5, 44-100 Gliwice, Poland; [email protected] (G.B.); [email protected] (M.C.); [email protected] (J.M.); [email protected] (M.D.) * Correspondence: [email protected]; Tel.: +48-32-238-06-57; Fax: +48-32-231-69-33 Academic Editor: Hugo F. Lopez Received: 23 December 2016; Accepted: 9 March 2017; Published: 15 March 2017 Abstract: This paper is devoted to the preparation of high-purity anhydrous nanocrystalline cesium perrhenate, which is applied in catalyst preparation. It was found that anhydrous cesium perrhenate with a crystal size <45 nm can be obtained using cesium ion sorption and elution using aqueous solutions of perrhenic acid with subsequent crystallisation, purification, and drying. The following composition of the as-obtained product was reported: 34.7% Cs; 48.6% Re and <2 ppm Bi; <3 ppm Zn; <2 ppm As; <10 ppm Ni; < 3 ppm Mg; <5 ppm Cu; <5 ppm Mo; <5 ppm Pb; <10 ppm K; <2 ppm Na; <5 ppm Ca; <3 ppm Fe. Keywords: cesium; caesium; rhenium; perrhenate; cation resin 1. Introduction Both cesium and rhenium are classified as rare metals with naturally occurring deposits scattered around the world [1,2]. Molybdenites from porphyry copper deposits are the most important rhenium sources, while cesium can be mainly found in pollucite (CsAlSi2O6)[1–3]. Rhenium can be characterised by a high melting temperature (3453 K) and high density (21.0 g/cm3).
    [Show full text]
  • The Mechanism of Rhenium Fixation in Reducing Sediments
    ABSTRACT Title: THE MECHANISM OF RHENIUM FIXATION IN REDUCING SEDIMENTS Marvourneen Kimranee Dolor, Master of Science, 2005 Directed By: Professor George R. Helz, Department of Chemistry and Biochemistry There is a wide range of uses of information related to rhenium’s geochemical behavior. Field studies indicate that rhenium is highly enriched in reducing sediments. However the mechanisms by which this high degree of enrichment is - achieved are unclear. Perrhenate’s (ReO4 ) sorption onto a clay mineral, kaolinite, was investigated and found to be weak. This behavior is consistent with rhenium’s conservative behavior in the oceans. Sorption was enhanced by the presence of a reducing agent, lithium borohydride. The presence of sulfide, a reducing agent found - in nature, enhanced sorption slightly. Sulfide apparently does not reduce ReO4 rapidly as shown by the failure of polysulfide species to appear in solution. Instead, sulfide causes the formation of thioperrhenates. The mechanism of thiolation is the successive replacement of oxygen atoms in - - - ReO4 by sulfur atoms, but ReO3S and ReS4 are the only thioperrhenates observed by - - UV-Vis spectroscopy. The di- and tri- thioperrhenates, ReO2S2 and ReOS3 are - absent due to their relative instability. Thiolation of ReO4 appears to be general-acid - - catalyzed. Quantitative yield of ReS4 from ReO4 was never achieved. Thioperrhenates undergo polymerization in solution to yield a colloidal Re-S species, probably related to Re2S7, which contains polysulfide ions in its structure. This Re-S polymer is stable under different experimental conditions and thermodynamic calculations confirm that it is a very stable, insoluble species. Sulfide may play an important role in Re enrichment in sediments by leading to the formation of this solid Re-S species.
    [Show full text]
  • Crystallization of Sodium Perrhenate from Nareo4–H2O–C2H5OH Solutions at 298 K Jesús M
    Hydrometallurgy 113–114 (2012) 192–194 Contents lists available at SciVerse ScienceDirect Hydrometallurgy journal homepage: www.elsevier.com/locate/hydromet Crystallization of sodium perrhenate from NaReO4–H2O–C2H5OH solutions at 298 K Jesús M. Casas ⁎, Elizabeth Sepúlveda, Loreto Bravo, Luis Cifuentes Departamento de Ingeniería de Minas, Universidad de Chile, Av. Tupper 2069, F: 56-9-9837.8538, Santiago, Chile article info abstract Article history: Crystallization of sodium perrhenate (NaReO4) from aqueous solution was studied by means of laboratory Received 4 August 2011 scale experiments at 298 K. NaReO4 has a very high solubility in aqueous solution (>1130 g/L at 298 K) so Received in revised form 24 December 2011 crystallization was induced by the addition of ethanol (drowning-out crystallization process). This resulted Accepted 25 December 2011 in well crystalline NaReO particles which required less energy and water than the conventional evaporative Available online 29 December 2011 4 crystallization industrial process. The crystallization of NaReO4 took 5–10 min and could be achieved in 1 or 2 stages by controlling the solution super-saturation by the addition of ethanol in the 25–75 vol.% range. The Keywords: Rhenium ethanol in solution could be recovered by distillation and recycled. Sodium perrhenate © 2011 Elsevier B.V. All rights reserved. Crystallization Drowning-out Ethanol 1. Introduction Sodium perrhenate (NaReO4) is produced from ammonium per- rhenate (NH4ReO4) by an evaporative crystallization process Rhenium (Re) is a rare transition metal present in nature in very (363–373 K), where the salt is precipitated by thermal evaporation low concentration (0.4 mg/t), the only commercial recovery is from of water which has a high energy cost (about 47 MJ/kg NaReO4).
    [Show full text]
  • Rac-DMSA in Nude Mice Xenografted with A
    Nuclear Imaging with 188 Re(V)- meso -DMSA and 188 Re(V)- rac -DMSA in nude mice xenografted with a neuroendocrine tumor cells Jun Young Park The Graduate School Yonsei University Department of Biomedical Laboratory Science Nuclear Imaging with 188 Re(V)- meso -DMSA and 188 Re(V)- rac -DMSA in nude mice xenografted with a neuroendocrine tumor cells A Masters Thesis Submitted to the Department of Biomedical Laboratory Science and the Graduate School of Yonsei University in partial fulfillment of the requirements for the degree of Master of Science Jun Young Park December 2006 This certifies that the masters thesis of Jun Young Park is approved. ___________________________ Thesis Supervisor : Ok Doo Awh ___________________________ Tae Woo Kim : Thesis Committee Member ___________________________ Yong Serk Park : Thesis Committee Member The Graduate School Yonsei University December 2006 - Intelligence without ambition is a bird without wings - Salvador Dali - Life is what happens to you, While you're busy making other plans - John Lennon for Mom, Daddy & Special thanks to Prof. Awh O.D., Phd. Choi T.H., Phd. Lee T.S. CONTENTS LIST OF FIGURES ·································································································ⅲ LIST OF TABLES ···································································································ⅳ ABBREVIATION ······································································································ⅴ ABSTRACT IN ENGLISH ·····················································································ⅵ
    [Show full text]
  • Radiopharmacology of a Simplified Technetium-99M- Colloid Preparation for Photoscanning1
    JOURNAL OF NUCLEAR MEDICINE 7:817-826, 1966 Radiopharmacology of a Simplified Technetium-99m- Colloid Preparation for Photoscanning1 Steven M. Larson2 and Wit B. Nelp3 Seattle, Washington INTRODUCTION Currently, the usefulness of colloidal preparations of technetium-99m is being evaluated for photoscanning the organs of the RES, i.e. the liver, spleen and bone marrow. The low radiation exposure resulting from internal administration of 9amTc colloid and the easily collimated 140 key gamma emission, are the at tractive features of this radiopharmaceutical. Because of the six-hour half-life of 99@'Tc,the colloid must be prepared on the day it is used. Consequently, the method of preparation of the colloid must be relatively rapid and simple. A satisfactory method for preparing colloidal o9mtechnetium heptasulfide (Tc2S7) has been developed by Harper and associates (1). Although this tech nique is not complicated, it requires 30 to 60 minutes of preparation time and employs a reaction between pertechnetate ion (TcO4j and hydrogen sulfide. The latter requires use of a fume hood and because of the potential toxicity of hydro gen sulfide, excess gas must be purged from the reaction mixture prior to admin istration of the final product. A method for preparing 99@'Tc-sulfur colloid by reacting Tc04 —with thiosul fate in sulfuric acid has been developed by Stern (2). This method employs car boxy methyl cellulose (CMC) as a colloidal stabilizer. This agent is relatively insoluble and is dissolved in pertechnetate solution only after heating for 15 minutes at 80°C. During preparation of CMC stabilized colloid, pH of reaction must be carefully controlled and the colloidal product sterilized by autoclaving.
    [Show full text]
  • Aqueous Geochemistry of Rhenium and Chromium in Saltstone
    Clemson University TigerPrints All Theses Theses 12-2013 Aqueous Geochemistry of Rhenium and Chromium in Saltstone: Implications for Understanding Technetium Mobility in Saltstone Amanda Hatfield Clemson University, [email protected] Follow this and additional works at: https://tigerprints.clemson.edu/all_theses Part of the Environmental Sciences Commons Recommended Citation Hatfield, Amanda, "Aqueous Geochemistry of Rhenium and Chromium in Saltstone: Implications for Understanding Technetium Mobility in Saltstone" (2013). All Theses. 1813. https://tigerprints.clemson.edu/all_theses/1813 This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized administrator of TigerPrints. For more information, please contact [email protected]. AQUEOUS GEOCHEMISTRY OF RHENIUM AND CHROMIUM IN SALTSTONE: IMPLICATION FOR UNDERSTANDING TECHNETIUM MOBILITY IN SALTSTONE A Thesis Presented to the Graduate School of Clemson University In Partial Fulfillment of the Requirements for the Degree Master of Science Environmental Toxicology by Amanda Cecilia Hatfield December 2013 Accepted by: Dr. Yuji Arai, Committee Co-Chair Dr. Cindy Lee, Committee Co-Chair Dr. Daniel Kaplan Dr. Brian A. Powell ABSTRACT Incorporation of low level radioactive waste in cementitious materials is an important waste disposal technology in practice at a U.S. DOE facility, the Savannah 99 River Site (SRS), Aiken, SC. One of the major risk drivers, technetium ( Tc) (t1/2: 2.11 x 105 y), has been immobilized in saltstone through reductive precipitation. The saltstone VII - mixture is used to achieve chemical reduction of soluble Tc O4 (aq) into relatively IV insoluble Tc species (oxides and sulfides) via the Fe/S based compounds in the slag component.
    [Show full text]
  • University of Oklahoma Graduate College Survey
    UNIVERSITY OF OKLAHOMA GRADUATE COLLEGE SURVEY OF CATALYST AND REDUCTANT EFFECTS ON OXORHENIUM CATALYZED DEOXYDEHYDRATION OF GLYCOLS A DISSERTATION SUBMITTED TO THE GRADUATE FACULTY in partial fulfillment of the requirements for the Degree of DOCTOR OF PHILOSOPHY By JAMES MICHAEL MCCLAIN II Norman, Oklahoma 2015 SURVEY OF CATALYST AND REDUCTANT EFFECTS ON OXORHENIUM CATALYZED DEOXYDEHYDRATION OF GLYCOLS A DISSERTATION APPROVED FOR THE DEPARTMENT OF CHEMISTRY AND BIOCHEMISTRY BY ______________________________ Dr. Kenneth M. Nicholas, Chair ______________________________ Dr. Robert P. Houser ______________________________ Dr. George Richter-Addo ______________________________ Dr. Robert K. Thomson ______________________________ Dr. Ronald L. Halterman ______________________________ Dr. Lee R. Krumholz © Copyright by JAMES MICHAEL MCCLAIN II 2015 All Rights Reserved. To my parents & sisters for a lifetime of love, support, and faith in my shenanigans, thank you. Acknowledgements I would not have made it to where I am today without the friendship, mentorship, encouragement, and support of countless people. I know I cannot adequately thank everyone responsible for influencing me to develop into the person I am today and I will inevitably leave out many who deserve recognition, to those individuals I apologize and greatly thank you. As a child, while working in my grandpa’s workshop he would always tell me “can’t ain’t a word” anytime I said I couldn’t do one thing or another. At the time I thought, ironically, he was giving me a grammatical lesson, it wasn’t till after his passing and I was older that I truly understood what he was telling me. This has become my general philosophy in life when challenges present themselves; I concede that it occasionally leads me to pursue endeavors off the main track but I owe most of my accomplishments to this stubbornness.
    [Show full text]
  • Material Safety Data Sheet
    Page 1/6 Material Safety Data Sheet According to OSHA and ANSI Printing date 05/27/2011 Reviewed on 12/08/2006 1 Identification of the substance/mixture and of the company/undertaking Product identifier Product name: Sodium perrhenate Stock number: 11412 CAS Number: 13472-33-8 EINECS Number: 236-742-9 Relevant identified uses of the substance or mixture and uses advised against. Sector of Use SU24 Scientific research and development Details of the supplier of the safety data sheet Manufacturer/Supplier: Alfa Aesar, A Johnson Matthey Company Johnson Matthey Catalog Company, Inc. 30 Bond Street Ward Hill, MA 01835-8099 Tel: 800-343-0660 Fax: 800-322-4757 Email: [email protected] www.alfa.com Information Department: Health, Safety and Environmental Department Emergency telephone number: During normal hours the Health, Safety and Environmental Department at (800) 343-0660. After normal hours call Carechem 24 at (866) 928-0789. 2 Hazards identification Classification of the substance or mixture GHS07 H315 Causes skin irritation. H319 Causes serious eye irritation. Classification according to Directive 67/548/EEC or Directive 1999/45/EC Xi; Irritant R36/38: Irritating to eyes and skin. O; Oxidizing R8: Contact with combustible material may cause fire. Label elements Labelling according to EU guidelines: Code letter and hazard designation of product: Xi Irritant O Oxidizing Risk phrases: 8 Contact with combustible material may cause fire. 36/38 Irritating to eyes and skin. Safety phrases: 26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Hazard description: WHMIS classification Classification system HMIS ratings (scale 0-4) (Hazardous Materials Identification System) HEALTH 1 Health (acute effects) = 1 FIRE 0 Flammability = 0 Reactivity = 0 REACTIVITY 0 (Contd.
    [Show full text]